SAC Capital Accumulates 5.8% Stake In Cubist Pharma (CBST)
In a 13G filing after the close Friday on Cubist Pharma. (Nasdaq: CBST), Steven Cohen's SAC Capital hedge fund disclosed a 5.8%, or 3,465,768 share, stake in the company.
The hedge fund held just 59,188 shares at the end of the latest quarter, 12/31/10.
Get immediate access to market moving news and alerts with StreetInsider.com Premium - FREE TRIAL!
The hedge fund held just 59,188 shares at the end of the latest quarter, 12/31/10.
Get immediate access to market moving news and alerts with StreetInsider.com Premium - FREE TRIAL!
You May Also Be Interested In
- Citadel Raises Stake in Blue Nile, Inc. (NILE) to 5.55%
- SAC Capital Raises Stake in Ciena Corporation (CIEN) to 5.24%
Create E-mail Alert Related Categories
13Gs, Hedge FundsRelated Entities
SAC Capital, Steven A. Cohen, Hedge Funds, 13GSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!

Up)